MENU
+Compare
ALEC
Stock ticker: NASDAQ
AS OF
Jul 18 closing price
Price
$1.59
Change
-$0.08 (-4.79%)
Capitalization
158.99M

ALEC Alector Forecast, Technical & Fundamental Analysis

Alector Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ALEC with price predictions
Jul 18, 2025

ALEC's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for ALEC turned positive on July 09, 2025. Looking at past instances where ALEC's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 08, 2025. You may want to consider a long position or call options on ALEC as a result. In of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALEC advanced for three days, in of 273 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 146 cases where ALEC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 62 cases where ALEC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALEC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ALEC broke above its upper Bollinger Band on July 09, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALEC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.680) is normal, around the industry mean (18.109). P/E Ratio (0.000) is within average values for comparable stocks, (58.647). ALEC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.460). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (1.764) is also within normal values, averaging (270.773).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALEC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ALEC is expected to report earnings to rise 14.63% to -46 cents per share on July 31

Alector ALEC Stock Earnings Reports
Q2'25
Est.
$-0.47
Q1'25
Beat
by $0.07
Q4'24
Beat
by $0.58
Q3'24
Beat
by $0.10
Q2'24
Beat
by $0.10
The last earnings report on May 08 showed earnings per share of -40 cents, beating the estimate of -47 cents. With 301.45K shares outstanding, the current market capitalization sits at 158.99M.
A.I. Advisor
published General Information

General Information

a developer of therapeutics for Alzheimer's disease and other neurodegenerative disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
131 Oyster Point Boulevard
Phone
+1 415 231-5660
Employees
244
Web
https://www.alector.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PWCDF39.440.51
+1.31%
Power Corp. of Canada
THNPY42.520.06
+0.14%
Technip Energies NV
POFCY0.12N/A
N/A
Petrofac Ltd
ITXXF2.20N/A
N/A
Itaconix plc
QGLDF0.01-0.07
-87.62%
Q-Gold Resources Ltd.

ALEC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ALEC has been loosely correlated with RGNX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ALEC jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALEC
1D Price
Change %
ALEC100%
-4.79%
RGNX - ALEC
51%
Loosely correlated
-6.10%
BEAM - ALEC
50%
Loosely correlated
+1.47%
LRMR - ALEC
49%
Loosely correlated
-3.31%
ARCT - ALEC
48%
Loosely correlated
-0.30%
SYRE - ALEC
47%
Loosely correlated
-3.55%
More